Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195481 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94861 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2022-05-19 | 2022-08-09 | 161006 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-01-17 | 2020-04-02 | 103555 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2019-09-05 | 2020-04-09 | 93149 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2024-08-30 | 2025-09-11 | 236376 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2017-08-02 | 2017-09-19 | 18017 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195456 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-07-09 | 2020-09-03 | 119895 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2021-11-11 | 2022-04-21 | 149113 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162300 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-11-28 | 2020-04-02 | 99944 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2025-06-19 | 2025-10-02 | 260636 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194071 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2020-07-16 | 2020-11-07 | 120488 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Actual shortage | 2025-10-16 | 2026-01-08 | 269675 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2025-02-13 | 2025-04-10 | 250384 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2025-08-14 | 2025-10-02 | 265214 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-12-17 | 2021-01-21 | 130296 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Actual shortage | 2025-10-10 | 2026-01-22 | 269223 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258565 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258616 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258619 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260534 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258577 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258768 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258783 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258496 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258484 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258490 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |